PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Biochemistry, School of Medicine, Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Clinical Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.\', \'Department of Pharmacology and Neurobiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/ddr.21762
?:doi
?:hasPublicationType
?:journal
  • Drug development research
is ?:pmid of
?:pmid
?:pmid
  • 33251593
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.65
?:rankingScore_hIndex
  • 53
?:title
  • Review of registered clinical trials for the treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33251593>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33251593>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all